HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jan A Bruijn Selected Research

Imipramine (Janimine)

6/2010Long-term response to successful acute pharmacological treatment of psychotic depression.
6/2007Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
11/2004Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder.
10/2004A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.
11/2002CPT performance in major depressive disorder before and after treatment with imipramine or fluvoxamine.
8/200224-Hour motor activity after treatment with imipramine or fluvoxamine in major depressive disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jan A Bruijn Research Topics

Disease

19Glomerulonephritis
01/2020 - 11/2002
11Vasculitis (Vasculitides)
01/2019 - 01/2002
11Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2018 - 01/2002
9Proteinuria
11/2019 - 11/2002
8Major Depressive Disorder (Major Depressive Disorders)
06/2010 - 08/2002
7Inflammation (Inflammations)
11/2021 - 02/2012
7Kidney Diseases (Kidney Disease)
01/2021 - 10/2002
6Diabetic Nephropathies (Diabetic Nephropathy)
01/2021 - 05/2011
6Neoplasms (Cancer)
06/2017 - 03/2009
6Necrosis
12/2010 - 01/2002
5IGA Glomerulonephritis (IGA Nephropathy)
04/2022 - 08/2003
5Hypertension (High Blood Pressure)
10/2020 - 06/2004
4Lupus Nephritis
04/2022 - 02/2002
4Albuminuria
03/2022 - 07/2004
4Pre-Eclampsia (Preeclampsia)
11/2021 - 11/2012
4Fibrosis (Cirrhosis)
01/2021 - 01/2002
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2018 - 01/2011
3Nephritis
01/2019 - 09/2003
3Atrophy
07/2007 - 01/2002
2Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
07/2021 - 01/2019
2Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
01/2019 - 01/2018
2Chronic Renal Insufficiency
01/2019 - 04/2003
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2017 - 01/2007
2Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
09/2016 - 01/2002
2Microscopic Polyangiitis
09/2016 - 01/2002
2Autoimmune Diseases (Autoimmune Disease)
11/2015 - 04/2012
2Graft vs Host Disease (Graft-Versus-Host Disease)
03/2009 - 11/2004
2Treatment-Resistant Depressive Disorder
10/2006 - 11/2004
2Delayed Graft Function
03/2004 - 01/2003
1Atopic Dermatitis (Atopic Eczema)
01/2020
1Disease Progression
01/2019
1IgA Vasculitis (Purpura, Schoenlein Henoch)
01/2019
1Diabetes Mellitus
03/2018
1Type 2 Diabetes Mellitus (MODY)
03/2018
1Infections
01/2017
1Membranous Glomerulonephritis (Membranous Nephropathy)
01/2017
1Hypertrophy
01/2017
1Obesity
04/2016
1Pregnancy Complications
11/2015
1Thrombotic Microangiopathies
09/2015
1Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
12/2012

Drug/Important Bio-Agent (IBA)

23Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2020 - 01/2002
9Messenger RNA (mRNA)IBA
01/2019 - 10/2002
7Complement System Proteins (Complement)IBA
01/2019 - 11/2012
6Imipramine (Janimine)FDA LinkGeneric
06/2010 - 08/2002
6Fluvoxamine (Luvox)FDA LinkGeneric
06/2007 - 08/2002
5Proteins (Proteins, Gene)FDA Link
11/2021 - 08/2003
5AutoantibodiesIBA
01/2019 - 01/2002
5AntibodiesIBA
01/2018 - 04/2002
4Biomarkers (Surrogate Marker)IBA
04/2022 - 05/2011
4ThrombomodulinIBA
11/2021 - 04/2016
4nephrinIBA
01/2019 - 08/2003
4Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2006 - 11/2002
3Glycoproteins (Glycoprotein)IBA
11/2021 - 10/2020
3CreatinineIBA
10/2020 - 11/2002
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2017 - 02/2012
3LithiumIBA
08/2006 - 11/2004
3Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
08/2006 - 11/2004
3Fibronectins (Fibronectin)IBA
11/2004 - 02/2002
3CytokinesIBA
11/2004 - 10/2002
2EndoglinIBA
10/2020 - 12/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 01/2017
2Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2019 - 03/2018
2Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
01/2019 - 03/2018
2antiglomerular basement membrane antibodyIBA
01/2018 - 11/2004
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018 - 02/2012
2PlasminogenIBA
01/2018 - 12/2010
2Rituximab (Mabthera)FDA Link
06/2017 - 02/2012
2Peroxidase (Myeloperoxidase)IBA
09/2016 - 02/2012
2HLA Antigens (Human Leukocyte Antigens)IBA
03/2009 - 01/2003
2anti-Thy antibodyIBA
10/2008 - 09/2003
2Antidepressive Agents (Antidepressants)IBA
10/2006 - 11/2004
2Tranylcypromine (Parnate)FDA LinkGeneric
10/2006 - 11/2004
2Phenelzine (Nardil)FDA Link
10/2006 - 11/2004
2CollagenIBA
11/2004 - 11/2002
2Transforming Growth Factor beta (TGF-beta)IBA
11/2004 - 04/2003
1EnzymesIBA
03/2022
1Sunitinib (Sutent)FDA Link
11/2021
1Angiogenesis InhibitorsIBA
11/2021
1Endothelin Receptors (Endothelin Receptor)IBA
07/2021
1ClusterinIBA
10/2020
1Heparitin Sulfate (Heparan Sulfate)IBA
11/2019
1GlycosaminoglycansIBA
11/2019
1Immunoglobulin A (IgA)IBA
10/2019
1Dihydrotachysterol (AT 10)IBA
01/2019
1Dynamins (Dynamin)IBA
01/2019
1Cathepsin LIBA
01/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Periodic AcidIBA
01/2018
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2017
1Myeloblastin (Proteinase 3)IBA
09/2016
1Matrix Metalloproteinases (MMPs)IBA
04/2016
1FibrinIBA
04/2016

Therapy/Procedure

4Therapeutics
12/2015 - 07/2007
3Kidney Transplantation
04/2016 - 11/2002
3Transplantation
04/2016 - 09/2003
2Islets of Langerhans Transplantation
11/2012 - 01/2011
2Plasma Exchange
07/2007 - 08/2006
2Aftercare (After-Treatment)
11/2002 - 08/2002